Skip to main content
. Author manuscript; available in PMC: 2015 Aug 13.
Published in final edited form as: Support Care Cancer. 2013 Aug 17;21(12):3461–3469. doi: 10.1007/s00520-013-1931-3

Table 4.

Time spent on caregiving and household chores and lost work time among partner caregivers of prostate cancer patients by patient and caregiver characteristics over 1 year after diagnosis

Mean lost workplace
hours (SD)
p Value Mean informal
caregiving hours (SD)
p Value Mean household
chore hours (SD)
p Value
Overall 134.1 (366.3) 65.9 (172.4) 76.2 (193.3)
Caregiver characteristics
  Age (years) 0.23 0.81 0.52
    <65 147 (410.6) 72.4 (193.5) 95.6 (211.2)
    65+ 45 (238.1) 62.8 (163.3) 67.2 (185.5)
  Race/ethnicity 0.89 0.03 0.83
    Non-Hispanic white 117.4 (366.3) 143.7 (316.9) 84.8 (231.9)
    Non-Hispanic black/Hispanic/Asian 104.2 (376.2) 44.5 (96.4) 73.9 (183.2)
  Employment <0.001 0.52 0.32
    Full time/part time/self-employed 276.9 (500.4) 76.4 (203.6) 94.4 (214.5)
    Retired/unemployed/unknown (14.7) (80.8) 52.7 (123.9) 53.3 (162.7)
  Education 0.87 0.04 0.02
    Some college or less 107 (371.0) 111.0 (258.5) 132.1 (289.0)
    College graduate or higher 120 (366.5) 33.1 (31.7) 35.7 (29.9)
  Household income (US$/year) 0.77 0.41 0.02
    <40,000 83.1 (485.3) 118 (278.3) 210 (374.4)
    40,000–74,999 67.5 (321.2) 81.3 (187.7) 32.5 (24.2)
    75,000+ 134.2 (353.1) 50.2 (136.1) 58.6 (148.5)
  Self-reported health at baseline 0.66 0.69 0.06
    Excellent/very good 94.7 (385.2) 57.5 (165.2) 120.4 (276.2)
    Good/fair/poor 129.6 (354.5) 72.3 (179.1) 42.6 (77.9)
Patient characteristics
  Insurance 0.17 0.63 0.18
    Medicare 203.2 (466.5) 74.6 (185.6) 53.7 (97.7)
    Private (non-Medicare) 31.8 (190.4) 48.9 (130.0) 29.8 (15.9)
    VA/military 101.3 (405) 35.8 (26.6) 102.4 (254.5)
  Employment 0.61 0.72 0.03
    Full time/part time/self-employed 97.2 (362.2) 71.8 (179.3) 36.4 (56.3)
    Retired/unemployed/unknown 137.4 (375.3) 58.2 (165.0) 128.6 (280.5)
  Disease classification 0.95 0.06 0.89
    Low risk 112 (358.5) 31.8 (21.4) 73.2 (174.3)
    Moderate/high risk 117.2 (378.6) 101.6 (242.0) 79.2 (211.8)
  Number of comorbidities 0.58 0.41 0.12
    0 66.7 (240.2) 99.2 (271.5) 139.6 (324.6)
    1 160.5 (399.8) 61.8 (129.8) 48.5 (90.1)
    2+ 97.5 (431.1) 34.7 (19.8) 47.7 (52.4)
  Change in EPICa domain summary scores (12-month vs. baseline)
    Urinary irritation function 0.82 0.92 0.88
      No/mild decrease 126.5 (365.8) 56.2 (147.6) 55.9 (134.4)
      Moderate/severe decrease 157.5 (445.5) 61.75 (63.6) 48.8 (64.3)
    Urinary incontinent function 0.98 0.1 0.41
      No/mild decrease 127.2 (356.8) 47.5 (134.0) 56.9 (143.4)
      Moderate/severe decrease 129.6 (404.2) 117.5 (247.1) 90.5 (215.3)
    Sexual 0.21 0.03 0.01
      No/mild decrease 79.6 (321.6) 29 (17.6) 37.5 (37.9)
      Moderate/severe decrease 185.6 (444.4) 106.4 (249.6) 147.1 (307.0)
    Survey site 0.17 0.57 0.68
      California 75.8 (298.4) 80.3 (211.6) 70.2 (193.9)
      Texas 101.3 (405) 39 (28.5) 113.8 (254.9)
      South Carolina 276 (517.5) 39.9 (49.0) 58.9 (100.4)

SD standard deviation

a

The Expanded Prostate Cancer Index Composite (EPIC) score (Wei et al. 2000)